Submitted by Anonymous (not verified) on 20 November 2023 - 9:39
Human medicines European public assessment report (EPAR): Glivec, imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome, Date of authorisation: 07/11/2001, Revision: 46, Status: Authorised
Source: